insights_auto
Why is PHIO up 2.33%?
Dive Deeperchevron_right
PHIO:NASDAQ
Phio Pharmaceuticals Corp
$0.88
arrow_upward
+2.33%(+0.020) 1D
$0.86
arrow_downward
-2.00% (-0.018)todayPre-market
Closed: Nov 2, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PHIO...
Open
$0.87
High
$0.90
Low
$0.86
Mkt. cap
10.22M
Avg. vol.
88.00K
Volume
0.00
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.39
Beta
0.84
Shares outstanding
11.62M
No. of employees
6
Open
$0.87
High
$0.90
Low
$0.86
Mkt. cap
10.22M
Avg. vol.
88.00K
Volume
0.00
52-wk high
$4.19
52-wk low
$0.81
EPS
-$1.39
Beta
0.84
Shares outstanding
11.62M
No. of employees
6
News stories
From web sources and news partners
MarketWatch
·
17 minutes ago
This signal from the corporate bond market has historically preceded big drawdowns for the S&P 500
Investing.com
·
28 minutes ago
Nasdaq sank -5.3%, but these AI strategies surged up to +9.3% in October
BigGo Finance
·
43 minutes ago
NYSE Taps Broadridge to Run Onchain Voting for Its Tokenized Stock Venue
The Motley Fool
·
48 minutes ago
The Company Behind the New York Stock Exchange Is Now Building on Hyperliquid. Here's What It Means for Investors.
Profile
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
About Phio Pharmaceuticals Corp